Side Effects: Published Phase 1/2 data on CJC-1295 alone reported mild facial flushing post-injection in some participants and no serious adverse events at studied doses (Teichman et al., PMID 16352683)
FDA documents show that the following seven peptides are under review
Instructions At the beginning of the treatment, 1 ampoule with 1 mlvitamin B 12 Lichtenstein (corresponding to 1000 micrograms of cyanocobalamin) is added twice a week in the first weeks after diagnosis
If you've ever been diagnosed with Leber's hereditary optic neuropathy or any kidney condition
But the federal agency warns that these unauthorized drugs, which are illegal, pose serious health risks, adding that it still needs to evaluate them for safety, efficacy, and quality. They have not been demonstrated, through scientific trials, to provide the health benefits that they claim, according to Health Canada in an April advisory